AII
WST icon

AGF Investments Inc’s West Pharmaceutical WST Stock Holding History

AGF Investments Inc’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,691
Closed -$1.26M – 716
2021
Q4 		$1.26M Buy
+2,691
New +$1.16M 0.01% 406
2020
Q4 		– Sell
-15
Closed -$4K – 856
2020
Q3 		$4K Buy
15
+11
+275% +$2.91K ﹤0.01% 723
2020
Q2 		$1K Buy
+4
New +$786 ﹤0.01% 807
2018
Q3 		– Sell
-45,818
Closed -$4.55M – 363
2018
Q2 		$4.55M Sell
45,818
-121,556
-73% -$11.2M 0.05% 202
2018
Q1 		$14.8M Sell
167,374
-18,341
-10% -$1.72M 0.16% 154
2017
Q4 		$18.3M Sell
185,715
-52,749
-22% -$5.17M 0.18% 146
2017
Q3 		$23M Buy
+238,464
New +$21.6M 0.25% 114

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

AGF Investments Inc's WST Position: Q1 2022 in Review

AGF Investments Inc sold out of West Pharmaceutical (WST) in Q1 2022, closing a stake of 2,691 shares — an estimated $1.26M sold.

AGF Investments Inc first reported a position in WST in Q3 2017 and held it in 7 quarters. The position peaked at $23M in Q3 2017. 716 funds tracked by Wall St. Rank hold WST as of Q1 2022.

  • AGF Investments Inc reported no remaining West Pharmaceutical position as of Q1 2022 after selling out during the quarter.
  • AGF Investments Inc sold 2,691 West Pharmaceutical shares in Q1 2022, an estimated $1.26M.
  • AGF Investments Inc first reported a position in West Pharmaceutical in Q3 2017 and held it in 7 quarters.
  • AGF Investments Inc's West Pharmaceutical position peaked at $23M in Q3 2017.
  • 716 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2022.

Based on AGF Investments Inc's 13F filing for Q1 2022, filed 10 May 2022.